Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 777

1.

Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply.

Schüpke S, Kastrati A.

N Engl J Med. 2020 Jan 30;382(5):487. doi: 10.1056/NEJMc1915621. No abstract available.

PMID:
31995702
2.

Relation of Hypocholesterolemia With Diabetes Mellitus in Patients With Coronary Artery Disease.

Ndrepepa G, Cassese S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2020 Jan 8. pii: S0002-9149(20)30011-4. doi: 10.1016/j.amjcard.2019.12.044. [Epub ahead of print]

PMID:
31955829
3.

Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon.

Ndrepepa G, Kastrati A.

EuroIntervention. 2020 Jan 17;15(13):1120-1122. doi: 10.4244/EIJV15I13A208. No abstract available.

4.

Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest - A propensity score-matched analysis.

Lahmann AL, Bongiovanni D, Berkefeld A, Kettern M, Martinez L, Okrojek R, Hoppmann P, Laugwitz KL, Mayr P, Cassese S, Byrne R, Kufner S, Xhepa E, Schunkert H, Kastrati A, Joner M.

PLoS One. 2020 Jan 15;15(1):e0218634. doi: 10.1371/journal.pone.0218634. eCollection 2020.

5.

Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.

Schüpke S, Kastrati A.

Eur Heart J. 2020 Jan 13. pii: ehz938. doi: 10.1093/eurheartj/ehz938. [Epub ahead of print] No abstract available.

PMID:
31930293
6.

Endovascular therapy of subclavian artery occlusive disease involving the vertebral artery origin.

Schneider V, Dirschinger R, Wustrow I, Müller A, Cassese S, Fusaro M, Kastrati A, Koppara T, Bergmann K, Laugwitz KL, Ibrahim T, Bradaric C.

Vasa. 2020 Jan 6:1-9. doi: 10.1024/0301-1526/a000842. [Epub ahead of print]

PMID:
31904303
7.

Hypocholesterolaemia and mortality in patients with coronary artery disease.

Ndrepepa G, Holdenrieder S, Cassese S, Xhepa E, Fusaro M, Kastrati A.

Eur J Clin Invest. 2020 Feb;50(2):e13194. doi: 10.1111/eci.13194. Epub 2020 Jan 9.

PMID:
31863458
8.

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.

Bikdeli B, McAndrew T, Crowley A, Chen S, Mehdipoor G, Redfors B, Liu Y, Zhang Z, Liu M, Zhang Y, Francese DP, Erlinge D, James SK, Han Y, Li Y, Kastrati A, Schüpke S, Stables RH, Shahzad A, Steg PG, Goldstein P, Frigoli E, Mehran R, Valgimigli M, Stone GW.

Thromb Haemost. 2020 Feb;120(2):348-362. doi: 10.1055/s-0039-1700872. Epub 2019 Dec 9.

PMID:
31820428
9.

Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.

Koch T, Cassese S, Xhepa E, Mayer K, Tölg R, Hoppmann P, Laugwitz KL, Byrne RA, Kastrati A, Kufner S.

Catheter Cardiovasc Interv. 2019 Dec 2. doi: 10.1002/ccd.28638. [Epub ahead of print]

PMID:
31789486
10.

Ticagrelor-based antiplatelet regimens in patients with atherosclerotic artery disease-A meta-analysis of randomized clinical trials.

Cassese S, Ndrepepa G, Byrne RA, Laugwitz KL, Schunkert H, Fusaro M, Alfonso F, Kastrati A.

Am Heart J. 2020 Jan;219:109-116. doi: 10.1016/j.ahj.2019.08.020. Epub 2019 Aug 31.

PMID:
31756624
11.

Ticagrelor monotherapy versus aspirin in patients undergoing multiple arterial or single arterial coronary artery bypass grafting: insights from the TiCAB trial.

Sandner SE, Schunkert H, Kastrati A, Wiedemann D, Misfeld M, Böning A, Tebbe U, Nowak B, Stritzke J, Laufer G, von Scheidt M.

Eur J Cardiothorac Surg. 2019 Nov 21. pii: ezz313. doi: 10.1093/ejcts/ezz313. [Epub ahead of print]

PMID:
31750899
12.

Association of shock index with short-term and long-term prognosis after ST-segment elevation myocardial infarction.

Ndrepepa G, Cassese S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Coron Artery Dis. 2019 Dec;30(8):575-583. doi: 10.1097/MCA.0000000000000802.

PMID:
31577621
13.

Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial.

Rheude T, Toelg R, Byrne RA, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M.

EuroIntervention. 2019 Oct 1. pii: EIJ-D-19-00488. doi: 10.4244/EIJ-D-19-00488. [Epub ahead of print] No abstract available.

14.

Ticagrelor-based antiplatelet regimens in patients treated with coronary artery bypass grafting: a meta-analysis of randomized controlled trials.

von Scheidt M, Bongiovanni D, Tebbe U, Nowak B, Stritzke J, Zhao Q, Zhu Y, Kastrati A, Cassese S, Schunkert H.

Eur J Cardiothorac Surg. 2020 Mar 1;57(3):520-528. doi: 10.1093/ejcts/ezz260.

PMID:
31566205
15.

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Džavík V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM.

N Engl J Med. 2019 Nov 21;381(21):2032-2042. doi: 10.1056/NEJMoa1908419. Epub 2019 Sep 26.

PMID:
31556978
16.

Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions: Mid-Term Angiographic and OCT Findings From the ISAR-OCT-CTO Registry.

Xhepa E, Cassese S, Rroku A, Joner M, Pinieck S, Ndrepepa G, Kastrati A, Fusaro M.

JACC Cardiovasc Interv. 2019 Oct 14;12(19):1889-1898. doi: 10.1016/j.jcin.2019.04.049. Epub 2019 Sep 11.

PMID:
31521651
17.

Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).

Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Schunkert H, Colleran R, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA.

Eur Heart J. 2019 Sep 11. pii: ehz594. doi: 10.1093/eurheartj/ehz594. [Epub ahead of print]

PMID:
31511862
18.

Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves.

Rheude T, Pellegrini C, Cassese S, Wiebe J, Wagner S, Trenkwalder T, Alvarez H, Mayr NP, Hengstenberg C, Schunkert H, Kastrati A, Husser O, Joner M.

EuroIntervention. 2020 Feb 20;15(14):1233-1239. doi: 10.4244/EIJ-D-19-00710.

19.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators.

N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1.

PMID:
31475799
20.

Prevalence and Clinical Impact of Iron Deficiency in Patients With Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Lessmann L, Wiebe J, Mayr NP, Michel J, Trenkwalder T, Kasel AM, Schunkert H, Kastrati A, Joner M, Husser O, Hengstenberg C.

Am J Cardiol. 2019 Nov 1;124(9):1442-1448. doi: 10.1016/j.amjcard.2019.07.051. Epub 2019 Aug 7.

PMID:
31474326
21.

Procedural and clinical performance of dual- versus single-catheter strategy for transradial coronary angiography: A meta-analysis of randomized trials.

Alushi B, Lauten A, Ndrepepa G, Leistner DM, Kufner S, Xhepa E, Landmesser U, Kastrati A, Cassese S.

Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28458. [Epub ahead of print]

PMID:
31448867
22.

Progress in Drug-Eluting Stent Technology: Have We Come to the End of the Road?

Kastrati A, Kufner S.

JACC Cardiovasc Interv. 2019 Sep 9;12(17):1661-1664. doi: 10.1016/j.jcin.2019.05.015. Epub 2019 Aug 14. No abstract available.

PMID:
31422084
23.

[2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)].

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic' PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO.

G Ital Cardiol (Rome). 2019 Jul-Aug;20(7-8 Suppl 1):1S-61S. doi: 10.1714/3203.31801. Italian. No abstract available.

PMID:
31379378
24.

Integrin ß1 polymorphisms and bleeding risk after coronary artery stenting.

Thienel M, Lüsebrink E, Kastrati A, Dannenberg L, Polzin A, Schulz C, Massberg S, Petzold T.

Mol Biol Rep. 2019 Dec;46(6):5695-5702. doi: 10.1007/s11033-019-05003-2. Epub 2019 Jul 29.

PMID:
31359383
25.

Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery.

Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz KL, Ibrahim T.

EuroIntervention. 2019 Dec 20;15(12):e1107-e1114. doi: 10.4244/EIJ-D-19-00187.

26.

Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

Baber U, Stefanini GG, Giustino G, Stone GW, Leon MB, Sartori S, Aquino M, Steg PG, Windecker S, Wijns W, Serruys PW, Valgimigli M, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari DE, von Birgelen C, Dangas GD, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R.

Circ Cardiovasc Interv. 2019 Jul;12(7):e007734. doi: 10.1161/CIRCINTERVENTIONS.118.007734. Epub 2019 Jul 10.

PMID:
31288561
27.

Influence of marital status in patients undergoing transcatheter aortic valve implantation.

Pellegrini C, Rheude T, Mahr L, Trenkwalder T, Mayr NP, Michel J, Schunkert H, Kasel AM, Joner M, Hengstenberg C, Kastrati A, Husser O, Kessler T.

J Thorac Dis. 2019 May;11(5):1888-1895. doi: 10.21037/jtd.2019.05.19.

28.

Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease.

Ndrepepa G, Holdenrieder S, Colleran R, Cassese S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Clin Chim Acta. 2019 Sep;496:55-61. doi: 10.1016/j.cca.2019.06.021. Epub 2019 Jun 27.

PMID:
31254501
29.

Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography.

Hoppmann P, Rai H, Colleran R, Kufner S, Wiebe J, Cassese S, Joner M, Laugwitz KL, Kastrati A, Byrne RA.

Cardiovasc Revasc Med. 2019 May 30. pii: S1553-8389(19)30322-7. doi: 10.1016/j.carrev.2019.05.023. [Epub ahead of print]

PMID:
31231028
30.

Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.

Schüpke S, Hein-Rothweiler R, Mayer K, Janisch M, Sibbing D, Ndrepepa G, Hilz R, Laugwitz KL, Bernlochner I, Gschwendtner S, Kupka D, Gori T, Zeiher AM, Schunkert H, Massberg S, Kastrati A; ISAR-PLASTER-Trial Investigators.

Thromb Haemost. 2019 Sep;119(9):1539-1545. doi: 10.1055/s-0039-1692423. Epub 2019 Jun 21.

PMID:
31226721
31.

Photochemical Amplifier Based on Self-Immolative Dendritic Spacers.

Kastrati A, Bochet CG.

J Org Chem. 2019 Jun 21;84(12):7776-7785. doi: 10.1021/acs.joc.9b00651. Epub 2019 Jun 11.

PMID:
31184892
32.

The Clinical Impact of Psoas Muscle Cross-Sectional Area on Medium-Term Mortality After Transcatheter Aortic Valve Implantation.

Michel J, Pellegrini C, Rheude T, von Scheidt M, Trenkwalder T, Elhmidi Y, Mayr NP, Brecker S, Kasel AM, Kastrati A, Schunkert H, Husser O, Bleiziffer S, Hengstenberg C.

Heart Lung Circ. 2019 May 23. pii: S1443-9506(19)30474-3. doi: 10.1016/j.hlc.2019.05.095. [Epub ahead of print]

PMID:
31182269
33.

Genetically modulated educational attainment and coronary disease risk.

Zeng L, Ntalla I, Kessler T, Kastrati A, Erdmann J; UK Biobank CardioMetabolic Consortium CHD Working Group, Danesh J, Watkins H, Samani NJ, Deloukas P, Schunkert H.

Eur Heart J. 2019 Aug 1;40(29):2413-2420. doi: 10.1093/eurheartj/ehz328.

PMID:
31170283
34.

Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stent.

Rai H, Hussein H, Colleran R, Xhepa E, Wiebe J, Pinieck S, Cassese S, Joner M, Kastrati A, Byrne RA, Foley DP.

Cardiovasc Revasc Med. 2019 May 8. pii: S1553-8389(19)30302-1. doi: 10.1016/j.carrev.2019.05.004. [Epub ahead of print]

PMID:
31155492
35.

Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.

Schunkert H, Boening A, von Scheidt M, Lanig C, Gusmini F, de Waha A, Kuna C, Fach A, Grothusen C, Oberhoffer M, Knosalla C, Walther T, Danner BC, Misfeld M, Zeymer U, Wimmer-Greinecker G, Siepe M, Grubitzsch H, Joost A, Schaefer A, Conradi L, Cremer J, Hamm C, Lange R, Radke PW, Schulz R, Laufer G, Grieshaber P, Pader P, Attmann T, Schmoeckel M, Meyer A, Ziegelhöffer T, Hambrecht R, Kastrati A, Sandner SE.

Eur Heart J. 2019 Aug 1;40(29):2432-2440. doi: 10.1093/eurheartj/ehz185.

PMID:
31145798
36.

Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.

Sager HB, Husser O, Steffens S, Laugwitz KL, Schunkert H, Kastrati A, Ndrepepa G, Kessler T.

J Transl Med. 2019 May 29;17(1):180. doi: 10.1186/s12967-019-1934-z.

37.

One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3.

Pellegrini C, Rheude T, Trenkwalder T, Mayr NP, Joner M, Kastrati A, Schunkert H, Husser O, Hengstenberg C.

Clin Res Cardiol. 2019 Nov;108(11):1258-1265. doi: 10.1007/s00392-019-01461-7. Epub 2019 May 2.

38.

Monocyte-platelet aggregates affect local inflammation in patients with acute myocardial infarction.

Kossmann H, Rischpler C, Hanus F, Nekolla SG, Kunze KP, Götze K, Goedel A, Sager H, Kastrati A, Sinnecker D, Kupatt C, Ibrahim T, Schwaiger M, Laugwitz KL, Dirschinger RJ.

Int J Cardiol. 2019 Jul 15;287:7-12. doi: 10.1016/j.ijcard.2019.04.009. Epub 2019 Apr 8.

PMID:
31003796
39.

Omission of aspirin after ACS or stenting in patients with oral anticoagulation - why have the goalposts moved?

Byrne RA, Colleran R, Kastrati A.

EuroIntervention. 2019 Apr 5;14(18):e1793-e1795. doi: 10.4244/EIJV14I18A312. No abstract available.

40.

Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?

Harada Y, Schneider S, Colleran R, Rai H, Bohner J, Kuna C, Kufner S, Giacoppo D, Schüpke S, Joner M, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA.

Rev Esp Cardiol (Engl Ed). 2020 Mar;73(3):225-231. doi: 10.1016/j.rec.2019.01.005. Epub 2019 Mar 14. English, Spanish.

PMID:
30878234
41.

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation.

Goedel A, Fiedler KA, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz KL, Kastrati A, Sarafoff N.

EuroIntervention. 2019 Oct 20;15(8):700-706. doi: 10.4244/EIJ-D-18-00995.

42.

One-year clinical outcome with a novel self-expanding transcatheter heart valve.

Pellegrini C, Rheude T, Trenkwalder T, Mayr NP, Michel J, Kastrati A, Schunkert H, Kasel AM, Joner M, Hengstenberg C, Husser O.

Catheter Cardiovasc Interv. 2019 Nov 15;94(6):783-792. doi: 10.1002/ccd.28144. Epub 2019 Feb 24.

43.

Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.

Xhepa E, Byrne RA, Rivero F, Rroku A, Cuesta J, Ndrepepa G, Kufner S, Valiente TB, Cassese S, Garcia-Guimaraes M, Lahmann AL, Rai H, Schunkert H, Joner M, Pérez-Vizcayno MJ, Gonzalo N, Alfonso F, Kastrati A.

Clin Res Cardiol. 2019 Sep;108(9):1059-1068. doi: 10.1007/s00392-019-01439-5. Epub 2019 Feb 19.

PMID:
30783752
44.

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.

Kessler T, Wolf B, Eriksson N, Kofink D, Mahmoodi BK, Rai H, Tragante V, Åkerblom A, Becker RC, Bernlochner I, Bopp R, James S, Katus HA, Mayer K, Munz M, Nordio F, O'Donoghue ML, Sager HB, Sibbing D, Solakov L, Storey RF, Wobst J, Asselbergs FW, Byrne RA, Erdmann J, Koenig W, Laugwitz KL, Ten Berg JM, Wallentin L, Kastrati A, Schunkert H.

Cardiovasc Res. 2019 Aug 1;115(10):1512-1518. doi: 10.1093/cvr/cvz015.

PMID:
30768153
45.

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials.

Cassese S, Katagiri Y, Byrne RA, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz KL, Windecker S, Kastrati A, Serruys PW.

EuroIntervention. 2019 Feb 5. pii: EIJ-D-18-01080. doi: 10.4244/EIJ-D-18-01080. [Epub ahead of print]

46.

Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction.

Ndrepepa G, Cassese S, Hashorva D, Kufner S, Xhepa E, Hasimi E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):901-909. doi: 10.1002/ccd.28098. Epub 2019 Jan 25.

PMID:
30680881
47.

U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction.

Ndrepepa G, Cassese S, Kufner S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Heart Vessels. 2019 Jul;34(7):1104-1112. doi: 10.1007/s00380-019-01344-x. Epub 2019 Jan 22.

PMID:
30671640
48.

2018 ESC/EACTS Guidelines on myocardial revascularization.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO.

EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/EIJY19M01_01. No abstract available.

49.

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.

Kufner S, Joner M, Thannheimer A, Hoppmann P, Ibrahim T, Mayer K, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA; ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents) Investigators.

Circulation. 2019 Jan 15;139(3):325-333. doi: 10.1161/CIRCULATIONAHA.118.038065.

PMID:
30586724
50.

[2018 ESC/EACTS Guidelines on myocardial revascularization].

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO.

Kardiol Pol. 2018;76(12):1585-1664. doi: 10.5603/KP.2018.0228. Polish. No abstract available.

Supplemental Content

Loading ...
Support Center